Crinetics Pharmaceuticals CRNX Business Segments — Income Tax
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Crinetics Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's business segments — income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's business segments — income tax?
- Crinetics Pharmaceuticals (CRNX) reported business segments — income tax of $45K in Q4 2025.
- What does business segments — income tax mean?
- Reflects the total tax liability recognized by the company based on its taxable income in various jurisdictions. Even for companies reporting net losses, this may include deferred tax adjustments or taxes paid in specific profitable regions. It is a standard measure of the company's tax burden and regulatory compliance costs.